Quality of life and self-esteem in children treated for idiopathic short stature

2002 ◽  
Vol 140 (5) ◽  
pp. 507-515 ◽  
Author(s):  
Nicolet C.M. Theunissen ◽  
Gerdine A. Kamp ◽  
Hendrik M. Koopman ◽  
Koos A.H. Zwinderman ◽  
Ton Vogels ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Short Stature ◽  
Self Esteem ◽  
Idiopathic Short Stature

Quality of life of young adults with idiopathic short stature: effect of growth hormone treatment

2007 ◽  
Vol 87 (8) ◽  
pp. 865-870 ◽  
Author(s):  
LTM Rekers-Mombarg ◽  
JJV Busschbach ◽  
GG Massa ◽  
J Dicke ◽  
JM Wit ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Growth Hormone ◽  
Young Adults ◽  
Short Stature ◽  
Growth Hormone Treatment ◽  
Hormone Treatment ◽  
Idiopathic Short Stature

Quality of Life in Adolescent Boys with Idiopathic Short Stature: Positive Impact of Growth Hormone and Aromatase Inhibitors

2018 ◽  
Vol 90 (6) ◽  
pp. 381-392 ◽  
Author(s):  
Monika Bullinger ◽  
Janika Bloemeke ◽  
Veronica Mericq ◽  
Rachel Sommer ◽  
Xiemena Gaete ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Growth Hormone ◽  
Short Stature ◽  
Aromatase Inhibitors ◽  
Positive Impact ◽  
Idiopathic Short Stature ◽  
Adolescent Males ◽  
Adolescent Boys ◽  
Open Label

Background: The combination of growth hormone (GH) and aromatase inhibitors (AI) improves linear growth in severely short adolescent boys; however, the effects of this intervention on quality of life (QoL) are unknown. This study assesses whether GH, AI, or their combination impacts the QoL of adolescent males with idiopathic short stature (ISS) from both the adolescent and the parent perspective. Method: A randomized open-label comparator trial was conducted in 76 pubertal males with ISS who received AI, GH, or AI/GH for 24 months. The condition-specific Quality of Life in Short Stature Youth questionnaire was used to assess QoL. Results: QoL scores were low at baseline in the children’s and parents’ reports. Within-group testing showed that total QoL scores increased significantly at 24 months in the GH and AI/GH group but not the AI group in the children’s report, whereas it increased in all of the groups in the parents’ report. Increases in QoL scores were associated with an increase in height SDS. Conclusions: Treatment with GH and AI/GH was associated with improved QoL scores as measured from both the patients’ and the parents’ perspectives, suggesting that the improved growth resulting from the use of these growth-promoting therapies has beneficial psychosocial effects in adolescent males with ISS followed for 24 months.

scholarly journals Evaluation of Quality of Life in Children with GH Deficiency and Idiopathic Short Stature Using the Child Behavior Checklist

2009 ◽  
Vol 18 (1) ◽  
pp. 15-22 ◽  
Author(s):  
Toshiaki Tanaka ◽  
Shigeru Tai ◽  
Yoji Morisaki ◽  
Katsuhiko Tachibana ◽  
Yasuko Kambayashi ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Short Stature ◽  
Child Behavior ◽  
Child Behavior Checklist ◽  
Gh Deficiency ◽  
Idiopathic Short Stature

Psychometric performance of the Quality of Life in Short Stature Youth (QoLISSY) questionnaire in a randomized open-label comparator trial in idiopathic short stature

2019 ◽  
Vol 32 (10) ◽  
pp. 1089-1101
Author(s):  
Janika Bloemeke ◽  
Richelle Balacano Valdez ◽  
Nelly Mauras ◽  
Veronica Mericq ◽  
Judith Ross ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Short Stature ◽  
Reliability And Validity ◽  
Idiopathic Short Stature ◽  
Response To Treatment ◽  
Open Label ◽  
Daily Growth ◽  
Psychometric Performance ◽  
Scale Scores

Abstract Background In addition to increasing linear growth, improvement in health-related quality of life (HRQOL) is an important endpoint in the treatment of short statured youth. Hence, condition-specific psychometric valid instruments that adequately assess HRQOL are needed. We aimed to confirmatorily examine the psychometric performance of the Quality of Life in Short Stature Youth (QoLISSY) questionnaire used in a previously reported prospective randomized open-label trial. Methods This trial compared treatment of idiopathic short stature (ISS) in 76 adolescent males with either oral aromatase inhibitors (AIs), subcutaneous daily growth hormone (GH) or a combination treatment (AI/GH) for at least 2 years, demonstrating improvements in HRQOL with the GH and AI/GH interventions. HRQOL was assessed from the child’s and parent’s perspectives with the short stature-specific QoLISSY and the generic KIDSCREEN questionnaires before and 24 months into treatment. Scale scores and psychometric properties were examined regarding reliability and validity of the QoLISSY questionnaire using the dataset from the published trial. Results The QoLISSY questionnaire showed high internal consistency and satisfactory criterion, convergent and known-groups validity. Scale scores were evenly distributed with no major floor or ceiling effects. Responsiveness analyses suggest that the QoLISSY questionnaire detects significant changes in HRQOL after 2 years of treatment with growth-promoting therapies in children with short stature from both the child’s and parent’s perspectives. Conclusions The QoLISSY questionnaire is a psychometrically sound, reliable and valid instrument that can explore the experiences associated with short stature, track HRQOL changes over time and in response to treatment, and highlight HRQOL domains that can be improved through intervention.

Mental Health Status and Health-Related Quality of Life among Systemic Lupus Erythematosus (SLE) Patients in Thailand: A Multi-Site Study

2020 ◽  
Vol 103 (11) ◽  
pp. 1185-1193
Keyword(s):  
Quality Of Life ◽  
Mental Health ◽  
Health Status ◽  
Lupus Erythematosus ◽  
Self Esteem ◽  
Mental Health Status ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

Background: The systemic lupus erythematosus (SLE) patients oftentimes suffer from both physical and psychosocial challenges that may lead to low health-related quality of life (HRQoL). However, limited research has been done in this area. Objective: To examined mental health status and HRQoL among SLE patients in Thailand. Materials and Methods: The present study was a cross-sectional study conducted at the rheumatology clinic of four major hospitals in Thailand. The paper-based questionnaire consisted of demographic, health history such as depression, anxiety, stress Scale (DASS-21), and the Rosenberg self-esteem scale (RSE), and the disease-specific Lupus Quality of Life scale (LupusQoL). Depending on the variable’s level of measurement such as categorical or continuous, Spearman’s Rho or Pearson’s product moment correlation coefficients were used to explore the relationships among the variables. Hierarchical multiple regression was used to identify the predictors of LupusQoL. Results: Among the 387 participants, many might have experienced depression, anxiety, and stress (30%, 51%, and 29%, respectively). Self-esteem among the participants was good (31.8 out of 40). All eight domains of LupusQoL were affected with intimate relationship domain being impacted the most. The overall LupusQoL was significantly associated with the number of prescribed medications (r=–0.23), depression (r=–0.70), anxiety (r=–0.58), stress (r=–0.67), and self-esteem (r=0.59), p<0.001. Significant predictors of the overall LupusQoL were mental health status (depression, anxiety, and stress) and self-esteem, F (3, 81)=43.10, p<0.001, adjusted R²=0.60. Conclusion: SLE patients should be holistically assessed in both physical and psychological aspects. In addition to proper medical treatments, healthcare providers should use a multidisciplinary team approach to resolve the patients’ psychosocial issues, which in turn, may increase the patients’ quality of life. Self-care education may be necessary to help the patients manage the condition and decrease the number of medications. Keywords: Mental health, Quality of life, SLE, Thailand

PSYCHOLOGICAL REHABILITATION AND SCREENING OF EMOTIONAL STRESS IN CANCER PATIENTS

2017 ◽  
Vol 63 (2) ◽  
pp. 316-319 ◽  
Author(s):  
Valentina Chulkova ◽  
Tatyana Semiglazova ◽  
Margarita Vagaytseva ◽  
Andrey Karitskiy ◽  
Yevgeniy Demin ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cancer Patient ◽  
Cancer Patients ◽  
Emotional Stress ◽  
Self Esteem ◽  
Breast Cancer Patients ◽  
Psychological Study ◽  
Psychological Assistance

Psychological rehabilitation is an integral part of rehabilitation of a cancer patient. Psychological rehabilitation is aimed at a patient adaptation in the situation of the disease and improvement his quality of life. Understanding of an oncological disease is extreme and (or) crisis situation and monitoring dynamics of the psychological statement of a patient allows using differentiated approach in the provision of professional psychological assistance. The modified scale of self-esteem level of distress (IPOS) was used for screening of mental and emotional stress of cancer patients. There were selected groups of cancer patients who were most in need of professional psychological assistance. Results of a psychological study of one of these groups - breast cancer patients - are presented.

Distress, proinflammatory cytokines and self-esteem as predictors of quality of life in breast cancer survivors

2021 ◽  
Vol 230 ◽  
pp. 113297
Author(s):  
Joana Perez-Tejada ◽  
Ibane Aizpurua-Perez ◽  
Ainitze Labaka ◽  
Oscar Vegas ◽  
Gurutze Ugartemendia ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cancer Survivors ◽  
Proinflammatory Cytokines ◽  
Breast Cancer Survivors ◽  
Self Esteem
Sign in / Sign up

Export Citation Format

Share Document